Shanghai MicroPort MedBot (Group) Past Earnings Performance
Past criteria checks 0/6
Shanghai MicroPort MedBot (Group)'s earnings have been declining at an average annual rate of -44.6%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 124.6% per year.
Key information
-44.6%
Earnings growth rate
-41.1%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 124.6% |
| Return on equity | -204.0% |
| Net Margin | -967.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Analysts Just Trimmed Their Revenue Forecasts By 58%
Apr 12
Is Shanghai MicroPort MedBot (Group) (HKG:2252) Using Debt Sensibly?
Mar 29Is Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 24We're Not Very Worried About Shanghai MicroPort MedBot (Group)'s (HKG:2252) Cash Burn Rate
May 19Here's Why We're Not Too Worried About Shanghai MicroPort MedBot (Group)'s (HKG:2252) Cash Burn Situation
Feb 02Revenue & Expenses BreakdownBeta
How Shanghai MicroPort MedBot (Group) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 105 | -1,012 | 365 | 569 |
| 30 Sep 23 | 86 | -1,116 | 397 | 650 |
| 30 Jun 23 | 68 | -1,220 | 430 | 731 |
| 31 Mar 23 | 45 | -1,180 | 392 | 743 |
| 31 Dec 22 | 22 | -1,140 | 355 | 756 |
| 30 Sep 22 | 12 | -970 | 302 | 662 |
| 30 Jun 22 | 3 | -800 | 249 | 569 |
| 31 Mar 22 | 3 | -691 | 218 | 481 |
| 31 Dec 21 | 2 | -583 | 187 | 393 |
| 30 Sep 21 | 1 | -489 | 137 | 324 |
| 30 Jun 21 | 0 | -396 | 88 | 255 |
| 31 Mar 21 | 0 | -299 | 59 | 195 |
| 31 Dec 20 | 0 | -203 | 30 | 135 |
Quality Earnings: 2252 is currently unprofitable.
Growing Profit Margin: 2252 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2252 is unprofitable, and losses have increased over the past 5 years at a rate of 44.6% per year.
Accelerating Growth: Unable to compare 2252's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2252 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.2%).
Return on Equity
High ROE: 2252 has a negative Return on Equity (-203.99%), as it is currently unprofitable.